WESTLAKE VILLAGE, Calif., May 8, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc . (Nasdaq: KYTH ) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference.
Event: Bank of America Merrill Lynch 2015 Health Care Conference Date: Thursday, May 14, 2015 Time: 10:40 a.m. PT
A live webcast will be available under the Investors section of the Company’s website at www.kythera.com . The presentation will be archived on the website and will be available for at least 14 days.
About KYTHERA
KYTHERA Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. Its lead product, KYBELLA™ (deoxycholic acid), is the first and only approved injectable drug for contouring moderate to severe submental fullness, a condition that is commonly referred to as a double chin. KYTHERA is also developing setipiprant (KYTH-105), an early-stage candidate for the prevention of male pattern baldness. KYTHERA’s longer-term strategy is to leverage its biotechnology and aesthetics experience to expand its product portfolio and pipeline. KYTHERA has submitted regulatory filings for ATX-101 in Canada, Switzerland and Australia. Find more information at www.kythera.com .
Investor Contact: Heather Rowe, Director, Investor Relations Tel: (818) 587- 4559 hrowe@kythera.com